Bright Minds Biosciences Inc (DRUG) Financials
$63.18
$-1.82
(-2.80%)
As on 11-Sep-2026 16:00EDT
Market cap
$620 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.9
Div. Yield
0 %
Cashflow (CA$ Mln) |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-8.69
|
-1.85
|
-7.02
|
-13.59
|
-7.32
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
85.57
|
0.81
|
2.19
|
5.20
|
26.06
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Financials Ratios |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (CA$)
|
-2.90
|
-1.71
|
-0.60
|
-1.95
|
-5.02
|
-3.60
|
|
|
|
|
|
|
Cash EPS (CA$)
|
-2.06
|
-1.70
|
-0.59
|
-1.94
|
-5.02
|
-3.60
|
|
|
|
|
|
|
Adjusted Book Value (CA$)
|
22.60
|
11.45
|
1.19
|
1.75
|
3.53
|
8.20
|
|
|
|
|
|
|
Dividend per Share (CA$)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share (CA$)
|
--
|
-1.21
|
-0.40
|
-1.86
|
-4.56
|
-3.09
|
|
|
|
|
|
|
Free Cash Flow per Share (CA$)
|
--
|
-1.21
|
-0.40
|
-1.86
|
-4.56
|
-3.09
|
|
|
|
|
|
Profitability Ratios |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
-27.85
|
-45.46
|
-84.96
|
-99.49
|
-84.60
|
|
|
|
|
|
|
ROE (%)
|
-12.45
|
-27.93
|
-46.18
|
-86.02
|
-99.95
|
-84.60
|
|
|
|
|
|
|
ROA (%)
|
-13.49
|
-27.02
|
-43.16
|
-77.74
|
-93.16
|
-81.41
|
|
|
|
|
|
|
EBIT Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Net Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Growth Ratios |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EBIT Growth (%)
|
-264.98
|
-336.46
|
61.99
|
50.74
|
-70.86
|
-1,766.07
|
|
|
|
|
|
|
Net Profit Growth (%)
|
-177.52
|
-336.46
|
61.99
|
50.74
|
-75.74
|
-1,652.32
|
|
|
|
|
|
|
EPS Growth (%)
|
-89.76
|
-1.83
|
0.69
|
0.61
|
-0.39
|
-8.03
|
|
|
|
|
|
|
Book Value Growth (%)
|
328.64
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.00
|
0.02
|
0.01
|
0.01
|
--
|
|
|
|
|
|
|
Short term debt to equity ratio
|
0.00
|
0.00
|
0.01
|
0.01
|
0.01
|
--
|
|
|
|
|
|
|
Current Ratio
|
121.97
|
36.10
|
11.32
|
24.26
|
8.11
|
31.38
|
|
|
|
|
|
|
Quick Ratio
|
121.97
|
--
|
--
|
24.39
|
--
|
--
|
|
|
|
|
|
|
Interest Coverage
|
-1,513.67
|
-475.09
|
--
|
-373.28
|
-67.17
|
--
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | Sep-20 | Sep-19 | Sep-18 | Sep-17 | Sep-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Asset Turnover
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Receivable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Inventory Days
|
--
|
--
|
--
|
-186.44
|
--
|
--
|
|
|
|
|
|
|
Payable days
|
--
|
7,007.85
|
--
|
3,601.31
|
55,751.20
|
--
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
